Taipei, Taiwan

Peiwen Yu

USPTO Granted Patents = 3 


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Taipei, TW (2021 - 2023)
  • San Diego, CA (US) (2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peiwen Yu

Introduction

Peiwen Yu, an accomplished inventor based in Taipei, Taiwan, has made significant strides in the field of immunotherapy through his groundbreaking research and patent contributions. With a total of three patents under his name, Yu is recognized for his innovative approaches to treating proliferative diseases, particularly cancer. His work at Obi Pharma Inc. exemplifies his commitment to enhancing therapeutic options for patients.

Latest Patents

Peiwen Yu's latest patents focus on immunogenic and therapeutic glycan compositions. One of his notable inventions includes a composition that encompasses Globo series antigens, such as SSEA-4, Globo H, and SSEA-3 glycoconjugates combined with therapeutic adjuvants like OBI-821 or OBI-834. These compositions are designed to treat proliferative diseases, primarily cancer, by acting as cancer vaccines that bolster the immune system's natural defenses against abnormal or damaged cells. The therapeutic conjugates creatively link antigens to carriers, including a KLH moiety, to enhance their efficacy in stimulating immune responses.

Another significant patent pertains to cancer immunotherapy, detailing methods for administering vaccines targeting Globo series antigens, specifically for patients with Metastatic Breast Cancer. This innovative approach advocates for selecting suitable candidates for immunotherapy, ultimately aiming to improve patient outcomes and promote significant immune responses.

Career Highlights

Throughout his career, Peiwen Yu has demonstrated exceptional expertise in therapeutic innovations. His role at Obi Pharma Inc. has allowed him to collaborate with fellow researchers and contribute to advancements in cancer treatment. Yu's dedication to research excellence and his ability to translate complex scientific concepts into practical therapies have set him apart in the field.

Collaborations

Peiwen Yu has collaborated with esteemed coworkers such as Shu-Yi Lin and Cheng-Der Tony Yu, further enriching the research environment at Obi Pharma Inc. Their combined skills and knowledge have fostered an atmosphere of innovation, leading to the development of patented therapies that hold promise for addressing pressing healthcare challenges.

Conclusion

Peiwen Yu stands as a testament to the power of innovation in the medical field. His contributions to immunotherapy, particularly in the realm of glycan compositions and cancer vaccines, position him as a leading figure in advancing treatment options for patients. As he continues his work at Obi Pharma Inc., the impact of his inventions will undoubtedly resonate within the scientific community and beyond, paving the way for future breakthroughs in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…